StockNews.com Begins Coverage on Ayala Pharmaceuticals (NASDAQ:ADXS)

StockNews.com started coverage on shares of Ayala Pharmaceuticals (NASDAQ:ADXS – Free Report) in a report issued on Monday morning. The brokerage issued a sell rating on the stock. Separately, LADENBURG THALM/SH SH restated a neutral rating on shares of Ayala Pharmaceuticals in a research note on Thursday, November 16th. Read Our Latest Report on Ayala […]

Leave a Reply

Your email address will not be published.

Previous post StockNews.com Begins Coverage on Bio-Path (NASDAQ:BPTH)
Next post Allakos (NASDAQ:ALLK) Upgraded at William Blair